Discovery and in vivo evaluation of novel RGD-modified Lipid-polymer hybrid nanoparticles for targeted drug delivery

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 17565-17576

  Zhao, Yinbo ^a   Lin, Dayong ^b   Wu, Fengbo ^a   Guo, Li ^a   He, Gu ^a   Ouyang, Liang ^a   Song, Xiangrong ^a   Huang, Wei ^c   Li, Xiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Curcumin; Lipid shell and polymer core hybrid nanoparticle (lpNP); PLGA; RGD

Indexed keywords

CURCUMIN; FLUORESCEIN ISOTHIOCYANATE; MACROGOL; NANOPARTICLE; POLYGLACTIN; RGD MODIFIED LIPID POLYMER HYBRID NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ARGINYL-GLYCYL-ASPARTIC ACID; CHOLESTEROL; DRUG CARRIER; LACTIC ACID; LIPID; MACROGOL DERIVATIVE; OLIGOPEPTIDE; POLYETHYLENE GLYCOL-CHOLESTEROL; POLYLACTIC ACID; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS ASSAY; ARTICLE; CANCER INHIBITION; CAPILLARY DENSITY; CELL SURVIVAL; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SCREENING; EMULSION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL LINE; MOUSE; MTT ASSAY; NANOENCAPSULATION; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NONHUMAN; PARTICLE SIZE; UMBILICAL VEIN ENDOTHELIAL CELL; ZETA POTENTIAL; ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CHOLESTEROL; CURCUMIN; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; LIPIDS; MELANOMA; MICE; MICE, INBRED BALB C; NANOPARTICLES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; POLYMERS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84907833333     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151017565     Document Type: Article

References (19)

1. Singh, S. From exotic spice to modern drug? Cell 2007, 130, 765-768.
2. Jagetia, G. C.; Aggarwal, B. B. Spicing up of the immune system by curcumin. J. Clin. Immunol. 2007, 27, 19-35.
3. Tang, H.; Murphy, C. J.; Zhang, B.; Shen, Y.; van Kirk, E. A.; Murdoch, W. J.; Radosz, M. Curcumin polymers as anticancer conjugates. Biomaterials 2010, 31, 7139-7149.
4. Gong, C. Y.; Wang, C.; Wang, Y. J.; Wu, Q. J.; Zhang, D. D.; Luo, F.; Qian, Z. Y. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale 2012, 4, 3095-3104.
5. Yallapu, M. M.; Jaggi, M.; Chauhan, S. C. Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discov. Today 2012, 17, 71-80.
6. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007, 4, 807-818.
7. Liu, L.; Sun, L.; Wu, Q. J.; Guo, W. H.; Li, L.; Chen, Y. S.; Li, Y. C.; Gong, C. Y.; Qian, Z. Y.; Wei, Y. Q. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int. J. Pharm. 2013, 443, 175-182.
8. Hadinoto, K.; Sundaresan, A.; Cheow, W. S. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm. 2013, 85, 427-443.
9. Zhao, P.; Wang, H.; Yu, M.; Liao, Z.; Wang, X.; Zhang, F.; Ji, W.; Wu, B.; Han, J.; Zhang, H. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2012, 81, 248-256.
10. Chitkara, D.; Kumar, N. BSA-PLGA-Based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm. Res. 2013, 30, 2396-2409.
11. Liu, Y.; Metasebya, S.; Samuel, A. Perspectives and potential applications of nanomedicine in breast and prostate cancer. Med. Res. Rev. 2013, 33, 3-32.
12. Patrick, V.; Michel, K. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery. Med. Res. Rev. 2013, 33, 457-516.
13. Jagat, R. K.; Sishir, K. K.; Rupinder K. K. Survivin signaling in clinical oncology: A multifaceted dragon. Med. Res. Rev. 2013, 33, 765-789.
14. Chan, J. M.; Zhang, L. F.; Yuet, K. P.; Liao, G.; Rhee, J. W.; Langer, R.; Farokhzad, O. C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009, 30, 1627-1634.
15. Li, J.; He, Z.; Yu, S.; Li, S.; Ma, Q.; Yu, Y.; Zhang, J.; Li, R.; Zheng, Y.; He, G.; et al. Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J. Biomed. Nanotechnol. 2012, 8, 809-817.
16. Messerschmidt, S. K. E.; Musyanovych A.; Altvater, M.; Scheurich P.; Pfizenmaier, K.; Landfester, K.; Kontermann, R. E. Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized articles to tumor cells. J. Control. Release 2009, 137, 69-72.
17. Fang, D.-L.; Chen, Y.; Xu, B.; Ren, K.; He, Z.-Y.; He, L.-L.; Lei, Y.; Fan, C.-M.; Song, X.-R. Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy. Int. J. Mol. Sci. 2014, 15, 3373-3388.
18. Jeanne, L.; Nathalie, M.; Lucie, L.; Céline, L.; Michel, B.; Daniel, S.; Jean, H. Design, synthesis and evaluation of enhanced DNA binding new lipopolythioureas. Bioconj. Chem. 2006, 17, 1200-1208.
19. Zeng, S.; Wu, F. B.; Li, B.; Song, X. R.; Zheng, Y.; He, G.; Peng, C.; Huang, W. Synthesis, characterization and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system. Sci. World J. 2014, doi: 10.1155/2014/546176.